Shukra Pharmaceuticals Limited (BOM:524632)
India · Delayed Price · Currency is INR 33.62
+1.60 (5.00%)
At close: May 6, 2026
Shukra Pharmaceuticals Market Cap
Shukra Pharmaceuticals has a market cap or net worth of 14.72 billion as of May 6, 2026. Its market cap has increased by 71.97% in one year.
Market Cap
14.72B
Enterprise Value
14.63B
Revenue
645.69M
Ranking
n/a
PE Ratio
84.78
Stock Price
33.62
Market Cap Chart
Since February 23, 2012, Shukra Pharmaceuticals's market cap has increased from 46.16M to 14.72B, an increase of 31,791.53%. That is a compound annual growth rate of 50.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 14.72B | -43.26% |
| Dec 31, 2025 | 25.94B | 334.48% |
| Dec 31, 2024 | 5.97B | 340.79% |
| Dec 29, 2023 | 1.35B | 554.74% |
| Dec 30, 2022 | 206.90M | 58.55% |
| Dec 30, 2021 | 130.50M | 105.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amrutanjan Health Care | 16.49B |
| Kwality Pharmaceuticals | 16.41B |
| Venus Remedies | 12.95B |
| Lincoln Pharmaceuticals | 12.93B |
| Syncom Formulations (India) | 12.91B |
| TTK Healthcare | 12.82B |
| Fredun Pharmaceuticals | 12.30B |
| Fermenta Biotech | 9.16B |